Effects of selective dopaminergic receptor stimulation on ventricular remodeling after experimental myocardial infarction in rats.

[1]  A. Skene,et al.  Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure , 1997, The Lancet.

[2]  W. Frishman,et al.  Selective and nonselective dopamine receptor agonists: an innovative approach to cardiovascular disease treatment. , 1996, American Heart Journal.

[3]  D. V. van Veldhuisen,et al.  Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure. , 1996, Journal of cardiac failure.

[4]  C. Semeraro,et al.  Peripheral dopaminergic activity of Z1046, a new mixed D1-like/D2-like-receptors agonist , 1995 .

[5]  F. Pocchiari,et al.  Z1046, a new dopaminergic agonist with high affinity for D1-like and D2-like receptor subtypes , 1995 .

[6]  C. Semeraro,et al.  Z1046, A new dopaminergic agent, reduces blood pressure in conscious SHR rats and cynomolgus monkeys , 1995 .

[7]  D. V. van Veldhuisen,et al.  Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captopril. , 1994, Journal of cardiovascular pharmacology.

[8]  N. Dhalla,et al.  Mechanisms of cardiac cell damage due to catecholamines: significance of drugs regulating central sympathetic outflow. , 1994, Journal of cardiovascular pharmacology.

[9]  B. D. de Smet,et al.  Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine. , 1993, Cardiovascular research.

[10]  J. Brouwer,et al.  Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). , 1993, Journal of the American College of Cardiology.

[11]  D. Faulds,et al.  Ibopamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in congestive heart failure. , 1993, Drugs & aging.

[12]  S. Rajfer,et al.  Role of dopamine receptors and the utility of dopamine agonists in heart failure. , 1990, Circulation.

[13]  G. Marchetti.  Pharmacological profile of ibopamine. A summary of experiments on anaesthesized dogs. , 1990, The Cardiology.

[14]  M. Packer.  Vasodilator and inotropic drugs for the treatment of chronic heart failure: distinguishing hype from hope. , 1988, Journal of the American College of Cardiology.

[15]  P. A. Todd,et al.  Ibopamine , 1988, Drugs.

[16]  M. Bristow,et al.  Myocardial α- and β-adrenergic receptors in heart failure: is cardiac-derived norepinephrine the regulatory signal? , 1988 .

[17]  M. Memo,et al.  Identification and characterization of postsynaptic D1- and D2-dopamine receptors in the cardiovascular system. , 1988, Journal of cardiovascular pharmacology.

[18]  R. Ferrini,et al.  Effect of ibopamine on diuresis and arterial blood pressure in anesthetized rats and its interactions with dopaminergic and alpha- and beta-adrenergic antagonists. , 1986, Arzneimittel-Forschung.

[19]  R. Ferrini,et al.  Activity of ibopamine on some isolated organs. , 1986, Arzneimittel-Forschung.

[20]  M. Pfeffer,et al.  Influence of Chronic Captopril Therapy on the Infarcted Left Ventricle of the Rat , 1985, Circulation research.

[21]  B. Westerink.  ANALYSIS OF TRACE AMOUNTS OF CATECHOLAMINES AND RELATED-COMPOUNDS IN BRAIN-TISSUE - A STUDY NEAR THE DETECTION LIMIT OF LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION , 1983 .

[22]  M. Pfeffer,et al.  Left Ventricular Diastolic Pressure‐Volume Relations in Rats with Healed Myocardial Infarction: Effects on Systolic Function , 1981, Circulation research.

[23]  S. Z. Langer.  Presynaptic regulation of the release of catecholamines. , 1980, Pharmacological reviews.

[24]  M. Pfeffer,et al.  Myocardial Infarct Size and Ventricular Function in Rats , 1979, Circulation research.

[25]  L. I. Goldberg,et al.  Cardiovascular and renal actions of dopamine: potential clinical applications. , 1972, Pharmacological reviews.

[26]  A. Steffens.  A method for frequent sampling of blood and continuous infusion of fluids in the rat without disturbing the animal , 1969 .